VRM
BSX icon

Vectors Research Management’s Boston Scientific BSX Stock Holding History

Vectors Research Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$559K Sell
13,103
-2,152
-14% -$117K 0.15% 101
2026
Q1 		$957K Buy
15,255
+68
+0.4% +$5.44K 0.28% 79
2025
Q4 		$1.45M Sell
15,187
-106
-0.7% -$10.4K 0.44% 65
2025
Q3 		$1.49M Buy
15,293
+3,912
+34% +$405K 0.47% 60
2025
Q2 		$1.22M Sell
11,381
-180
-2% -$18.2K 0.42% 62
2025
Q1 		$1.17M Buy
11,561
+555
+5% +$55.9K 0.41% 64
2024
Q4 		$983K Sell
11,006
-1,135
-9% -$99.9K 0.33% 70
2024
Q3 		$1.02M Sell
12,141
-14
-0.1% -$1.1K 0.31% 78
2024
Q2 		$936K Sell
12,155
-408
-3% -$29.9K 0.29% 79
2024
Q1 		$860K Buy
12,563
+1,685
+15% +$108K 0.24% 89
2023
Q4 		$629K Sell
10,878
-227
-2% -$12.1K 0.18% 99
2023
Q3 		$502K Sell
11,105
-16
-0.1% -$839 0.16% 96
2023
Q2 		$602K Buy
+11,121
New +$581K 0.17% 98

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vectors Research Management's BSX Position: Q2 2026 in Review

Vectors Research Management reduced its Boston Scientific (BSX) stake by 14% in Q2 2026, selling an estimated $117K and leaving 13,103 shares worth $559K. The position accounts for 0.15% of the portfolio, ranked #101.

Vectors Research Management first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.49M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vectors Research Management held 13,103 shares of Boston Scientific worth $559K as of Q2 2026.
  • Vectors Research Management sold 2,152 Boston Scientific shares in Q2 2026, an estimated $117K.
  • Boston Scientific made up 0.15% of Vectors Research Management's portfolio in Q2 2026, its #101 holding.
  • Vectors Research Management first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
  • Vectors Research Management's Boston Scientific position peaked at $1.49M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vectors Research Management's 13F filing for Q2 2026, filed 29 Jul 2026.